Prevalence of High On-treatment Platelet Reactivity in Diabetic Patients Treated with Aspirin
Authors:
- 1 January 2014
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 127 (1) , 95.e1-95.e9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Vascular Protection in People with DiabetesCanadian Journal of Diabetes, 2013
- Primary and secondary prevention of cardiovascular disease in diabetes with aspirinDiabetes & Vascular Disease Research, 2012
- Aspirin resistance: Effect of clinical, biochemical and genetic factorsPharmacology & Therapeutics, 2011
- Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage studyPharmacoepidemiology and Drug Safety, 2009
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled TrialJAMA, 2008
- The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseBMJ, 2008
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- The Effect of Aspirin Dosing on Platelet Function in Diabetic and Nondiabetic PatientsDiabetes, 2007
- Association of Laboratory-Defined Aspirin Resistance With a Higher Risk of Recurrent Cardiovascular EventsArchives of internal medicine (1960), 2007
- Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic PatientsDiabetes Care, 2003